Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)

Fig. 3

Kaplan–Meier survival curves showing the relationship between clinical remission at week 52 (A), loss of response (B), and colectomy (C) according to previous exposure to biologic therapy. Biologic naïve patients showed lower probability of loss of response as compared to biologic exposed patients (p = 0.003)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us